-
Process Optimization and Cost Control of Targeted Drugs: Accelerating Innovation in Biopharmaceuticals
David Orchard-Webb
September 03, 2024
In today's competitive drug development market, biopharmaceutical businesses are always under pressure to provide high-quality medicines swiftly and affordably.
-
Research and Development Status and Progress of Antibody Technology (Part I)
Xiaomichong
July 18, 2024
Antibody-based biological therapeutic drugs have been playing an increasingly important role in biopharmaceuticals due to their strong targeting, good specificity, and significant therapeutic effects.
-
Bio-conjugates: A Growing Class of Biopharmaceuticals
Shruti Talashi
March 08, 2024
The story of bioconjugates started with a desire to improve the functionality of a biomolecule used in basic research, drug delivery, diagnostic or medical devices.
-
Analysis on the Construction of Sustainable Development Capacity of Pharmaceutical Enterprises from the Aspect of Investment of R&D Expenses
Zhulikou431
December 17, 2021
Recently, semi-annual reports of domestic and foreign pharmaceutical companies have been disclosed one after another. From the data released by major companies, we put aside the highly anticipated...
-
The Next Horizon of Innovations in Drug Delivery
Neeta Ratanghayra
February 17, 2020
The rise of biopharmaceuticals and the growing interest towards patient-centricity has paved the way for some fascinating innovations in drug delivery.
-
3P Biopharmaceuticals and Nordic Nanovector Extend Partnership
contractpharma
June 26, 2019
For further biopharmaceutical development of Betalutin, a non-Hodgkin lymphoma (NHL) treatment.
-
Manufacturing small batches of biopharmaceuticals on demand
europeanpharmaceuticalreview
April 17, 2019
Portable biopharmaceutical drug manufacturers could be the future method of producing the drugs on demand for outbreaks of disease…
-
AstraZeneca Announces Organizational Changes
americanpharmaceuticalreview
January 08, 2019
AstraZeneca has announced organizational changes that include the arrival of oncology scientist, José Baselga.Other changes include the creation of .....
-
NEX China Helping Enterprises Explore New Directions as Plant Extract Market Rises Rapidly
en-cphi.cn
December 04, 2018
Market size of the plant extract industry in China is expected to reach RMB 24.9 billion in 2018, and to exceed RMB 34.1 billion by 2022
-
Mundipharma appoints former GSK exec as CFO
pharmaphorum
November 26, 2018
The Mundipharma network of independent pharma companies has appointed Arnaud Breabout as chief financial officer.